Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torasemide Tablets Bioequivalence Study Under Fasting and Fed Conditions
CTR20222260Phase 4Terminated
- Sponsor
- Suzhong Pharmaceutical Group Co., Ltd.
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of torasemide in chronic heart failure (CHF), sponsored by Suzhong Pharmaceutical Group Co., Ltd.. Started Oct 2022; status: terminated.
02
Drugs
torasemide
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on CTR20222260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222260.